|
1
|
Brody H: Colorectal cancer. Nature.
521:S12015. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mai D, Ding P, Tan L, Zhang J, Pan Z, Bai
R, Li C, Li M, Zhou Y, Tan W, et al: PIWI-interacting RNA-54265 is
oncogenic and a potential therapeutic target in colorectal
adenocarcinoma. Theranostics. 8:5213–5230. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dalmay T: Mechanism of miRNA-mediated
repression of mRNA translation. Essays Biochem. 54:29–38. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao H, Zheng C, Wang Y, Hou K, Yang X,
Cheng Y, Che X, Xie S, Wang S, Zhang T, et al: miR-1323 promotes
cell migration in lung adenocarcinoma by targeting Cbl-b and is an
early prognostic biomarker. Front Oncol. 10:1812020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Molist C, Navarro N, Giralt I, Zarzosa P,
Gallo-Oller G, Pons G, Magdaleno A, Moreno L, Guillén G, Hladun R,
et al: miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression
and exert anti-oncogenic effects in rhabdomyosarcoma. Cancer Lett.
477:49–59. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gharib E, Nasri Nasrabadi P and Reza Zali
M: miR-497-5p mediates starvation-induced death in colon cancer
cells by targeting acyl-CoA synthetase-5 and modulation of lipid
metabolism. J Cell Physiol. 235:5570–5589. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu X, He B, Xu T, Pan Y, Hu X, Chen X and
Wang S: MiR-490-3p functions as a tumor suppressor by inhibiting
oncogene VDAC1 expression in colorectal cancer. J Cancer.
9:1218–1230. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hou W, Zhang H, Bai X, Liu X, Yu Y, Song L
and Du Y: Suppressive role of miR-592 in breast cancer by
repressing TGF-β2. Oncol Rep. 38:3447–3454. 2017.PubMed/NCBI
|
|
10
|
Li Z, Li B, Niu L and Ge L: miR-592
functions as a tumor suppressor in human non-small cell lung cancer
by targeting SOX9. Oncol Rep. 37:297–304. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gao S, Chen J, Wang Y, Zhong Y, Dai Q,
Wang Q and Tu J: MiR-592 suppresses the development of glioma by
regulating Rho-associated protein kinase. Neuroreport.
29:1391–1399. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
He Y, Ge Y, Jiang M, Zhou J, Luo D, Fan H,
Shi L, Lin L and Yang L: MiR-592 promotes gastric cancer
proliferation, migration, and invasion through the PI3K/AKT and
MAPK/ERK signaling pathways by targeting Spry2. Cell Physiol
Biochem. 47:1465–1481. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fu Q, Du Y, Yang C, Zhang D, Zhang N, Liu
X, Cho WC and Yang Y: An oncogenic role of miR-592 in tumorigenesis
of human colorectal cancer by targeting Forkhead Box O3A (FoxO3A).
Expert Opin Ther Targets. 20:771–782. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Z, Wu R, Li G, Sun P, Xu Q and Liu Z:
MiR-592 inhibited cell proliferation of human colorectal cancer
cells by suppressing of CCND3 expression. Int J Clin Exp Med.
8:3490–3497. 2015.PubMed/NCBI
|
|
15
|
Cheng L, Xing Z, Zhang P and Xu W: Long
non-coding RNA LINC00662 promotes proliferation and migration of
breast cancer cells via regulating the miR-497-5p/EglN2 axis. Acta
Biochim Pol. 67:229–237. 2020.PubMed/NCBI
|
|
16
|
Chen Y, Wu N, Liu L, Dong H and Liu X:
microRNA-128-3p overexpression inhibits breast cancer stem cell
characteristics through suppression of Wnt signalling pathway by
down-regulating NEK2. J Cell Mol Med. 24:7353–7369. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen Z, Ren R, Wan D, Wang Y, Xue X, Jiang
M, Shen J, Han Y, Liu F, Shi J, et al: Hsa_circ_101555 functions as
a competing endogenous RNA of miR-597-5p to promote colorectal
cancer progression. Oncogene. 38:6017–6034. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Colwill K and Gräslund S; Renewable
Protein Binder Working Group, : A roadmap to generate renewable
protein binders to the human proteome. Nat Methods. 8:551–558.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Slattery ML, Herrick JS, Mullany LE,
Samowitz WS, Sevens JR, Sakoda L and Wolff RK: The co-regulatory
networks of tumor suppressor genes, oncogenes, and miRNAs in
colorectal cancer. Genes Chromosomes Cancer. 56:769–787. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang W, Zhang H, Tang M, Liu L, Zhou Z,
Zhang S and Wang L: MicroRNA-592 targets IGF-1R to suppress
cellular proliferation, migration and invasion in hepatocellular
carcinoma. Oncol Lett. 13:3522–3528. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jia YY, Zhao JY, Li BL, Gao K, Song Y, Liu
MY, Yang XJ, Xue Y, Wen AD and Shi L: miR-592/WSB1/HIF-1α axis
inhibits glycolytic metabolism to decrease hepatocellular carcinoma
growth. Oncotarget. 7:35257–35269. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lv Z, Rao P and Li W: MiR-592 represses
FOXO3 expression and promotes the proliferation of prostate cancer
cells. Int J Clin Exp Med. 8:15246–15253. 2015.PubMed/NCBI
|
|
25
|
Liu M, Zhi Q, Wang W, Zhang Q, Fang T and
Ma Q: Up-regulation of miR-592 correlates with tumor progression
and poor prognosis in patients with colorectal cancer. Biomed
Pharmacother. 69:214–220. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cheetham S, Tang MJ, Mesak F, Kennecke H,
Owen D and Tai IT: SPARC promoter hypermethylation in colorectal
cancers can be reversed by 5-Aza-2′deoxycytidine to increase SPARC
expression and improve therapy response. Br J Cancer. 98:1810–1819.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Drev D, Harpain F, Beer A, Stift A, Gruber
ES, Klimpfinger M, Thalhammer S, Reti A, Kenner L, Bergmann M, et
al: Impact of fibroblast-derived SPARC on invasiveness of
colorectal cancer cells. Cancers (Basel). 11:112019. View Article : Google Scholar
|
|
28
|
Deng Z, Wu J, Xu S, Chen F, Zhang Z, Jin A
and Wang J: Exosomes-microRNAs interacted with gastric cancer and
its microenvironment: A mini literature review. Biomarkers Med.
14:141–150. 2020. View Article : Google Scholar
|
|
29
|
Kim SM, Yang Y, Oh SJ, Hong Y, Seo M and
Jang M: Cancer-derived exosomes as a delivery platform of
CRISPR/Cas9 confer cancer cell tropism-dependent targeting. J
Control Release. 266:8–16. 2017. View Article : Google Scholar : PubMed/NCBI
|
